Trade Mark Journal No.2026/028 10 July 2026

WO0000001924369 (5,42,44)

Office of origin: United States of America

Date of International Registration:23 January 2026
Date of designation in the UK: 23 January 2026
Image for mark 1924369 SWORD AND SHIELD

International priority date claimed: 25 July 2025 (United States of America) (99303370)
Class 5
Therapeutic preparations, namely, cellular immunotherapies for cancer, autoimmune diseases and transplant rejections.
Class 42
Medical and clinical research and development services in the field of cellular immunotherapies; consulting services in the field of cellular immunotherapies; medical laboratory, research, pre-clinical, and clinical testing services, namely, providing medical laboratory, research, pre-clinical, and clinical testing services for others.
Class 44
Providing information, namely, providing medical and scientific information in the field of cellular immunotherapies; providing medical and scientific information in the field of therapeutic preparations.

Fate Therapeutics, Inc.

Representative: Jared M. Barrett Seed Intellectual Property Law Group LLP, 701 5th Avenue, Suite 5400, Seattle WA 98104, UNITED STATES OF AMERICA